Health
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2 – Technology Networks
Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they’re extracted from llamas and camels, which is problematic for…
Llamas, camels and COVID-19
For SARS-CoV-2 to infect humans, the viral Spike (S) protein must interact with and bind to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. The S protein achieves this via the receptor binding domains (RBDs), and thus blocking the RBD using antibodies is just one therapeutic avenue that is being explored for the treatment of SARS-CoV-2. Back in May, Technology Networks covered the work of scientists exploring the potential utility of…
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General22 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News6 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business10 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?